A CD6-targeted antibody-drug conjugate as a potential therapy for T cell–mediated disorders is a research paper published in JCI Insight (2023). On theSindex it has a DataRank of 0. It has been cited 14 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIH
Grant: EY033243
NCI NIH HHS
Grant: R21 CA287325
NEI NIH HHS
Grant: R21 EY031087
NEI NIH HHS
Grant: R41 EY033243
NIAID NIH HHS
Grant: UM1 AI144298
NEI NIH HHS
Grant: R01 EY030111
NEI NIH HHS
Grant: R01 EY025373
NHLBI NIH HHS
Grant: U54 HL119810
NEI NIH HHS
Grant: R01 EY034077
NIAID NIH HHS
Grant: UM1 AI110498
National Institutes of Health
Grant: 5U54HL119810-07
The Cleveland Clinic Innovation Accelerator
FWCI
1.71
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals